Travel Vaccines Market To Worth USD 7,137.89 Million By 2030 At CAGR Of 10.2%
Travel Vaccines Market Overview:
The Travel
Vaccines Market Report is experiencing significant growth as more
people recognize the importance of protecting their health while traveling. The
market is driven by factors such as the increasing number of international travellers,
growing awareness about travel-related diseases, and government initiatives to
promote vaccination.
Travel
Vaccines Market Size was valued at USD 3,290.00 Million in 2022 and is
projected to reach USD 7,137.89 Million by 2030, growing at a CAGR of 10.2%
during the forecast period.
Market Definition:
Travel
vaccines are a specialized category of vaccines designed to protect individuals
from infectious diseases that may be prevalent in specific travel destinations.
These vaccines are administered to individuals who are planning to travel
internationally or to regions where there is an increased risk of exposure to
certain diseases.
Market Drivers:
The steady
rise in international travel has significantly fuelled the demand for travel
vaccines. As more people embark on travel adventures, explore new destinations,
and engage in various activities, the need for protection against
travel-related diseases becomes paramount. The growing number of travellers,
both for business and leisure purposes, is a significant driver for the travel
vaccines market.
There is an
increasing awareness among individuals about the potential health risks
associated with travel. People are becoming more informed about diseases
prevalent in different regions and the importance of preventive measures, such
as travel vaccines, to safeguard their health. This heightened awareness drives
the demand for travel vaccines as travellers seek to protect themselves against
specific diseases they may encounter during their journeys.
Browse Here: To Get
Travel Vaccines Market Full Report
Market Challenges:
One of the
significant challenges in the travel vaccines market is the cost associated
with vaccines and related services. Travel vaccines can be expensive,
especially for individuals without adequate insurance coverage. The cost of
consultation fees, administration charges, and multiple doses of vaccines can
deter some travellers from seeking the necessary immunizations. Affordability
remains a barrier for certain individuals, particularly those with limited
financial resources.
Vaccine
hesitancy, which refers to the reluctance or refusal to vaccinate despite the
availability of vaccines, is a challenge faced by the travel vaccines market as
well. Some individuals may have concerns about the safety, efficacy, or side
effects of vaccines. Misinformation or misconceptions about vaccines can
contribute to vaccine hesitancy, leading to lower uptake of travel vaccines.
Market Segmentation:
By Composition
·
Mono
Vaccines
·
Combination
Vaccines
By Disease Type
·
Hepatitis
A
·
DPT
·
Yellow
Fever
·
Typhoid
·
Hepatitis
B
·
Measles
and Mumps
·
Rabies
·
Meningococcal
·
Japanese
Encephalitis
·
Others
By Traveller Type
·
Inbound
·
Outbound
Regional Analysis:
The United
States and Canada are major contributors to the travel vaccines market in North
America. The region has a well-established healthcare system, with a focus on
preventive healthcare and travel medicine. High levels of international travel,
both for business and leisure purposes, drive the demand for travel vaccines.
China,
Japan, India, Australia, and South Korea are key markets for travel vaccines in
the Asia-Pacific region. Rising disposable incomes, increasing international
travel, and Travel
Vaccines growing awareness of travel-related health risks drive market
growth in this region. The region is diverse, with variations in healthcare
systems, vaccination policies, and access to travel clinics.
Key Players of the Travel Vaccines
Market:
The travel
vaccines market is characterized by the presence of several key players who
compete to meet the travel vaccines growing
demand for travel-related immunizations. The competitive landscape is
dynamic and constantly evolving. Here are some of the key elements and players
in the competitive landscape:
·
GSK plc.
·
Sanofi
·
Merck & Co. Inc.
·
Pfizer Inc.
·
Bavarian Nordic
·
Emergent
·
Seqirus
·
Valneva SE
·
Abbott
·
AstraZeneca
Recent Developments:
GlaxoSmithKline (2022): In 2022, GlaxoSmithKline, a leading
vaccine manufacturer, announced the initiation of clinical trials for a novel
malaria vaccine. The development of an effective malaria vaccine is essential
for travellers visiting regions with a high risk of malaria transmission.
Johnson & Johnson (2022): In 2022, Johnson & Johnson
announced the approval of its single-dose Ebola vaccine by the European
Commission. This development marks a significant advancement in preventing and
controlling Ebola outbreaks in regions where the disease is prevalent,
impacting the travel vaccines market.
About CBI
Consegic Business Intelligence Pvt
Ltd. is the leading research industry that offers
contextual and data-centric research services to its customers across the
globe. The firm assists its clients to strategize business policies and
accomplish sustainable growth in their respective market domains. The industry
provides consulting services, syndicated research reports, and customized
research reports.
Topnotch research organizations and institutions to
comprehend the regional and global commercial status use the data produced by
Consegic Business Intelligence Pvt Ltd. Our reports comprise in-depth
analytical and statistical analysis on various industries in foremost countries
around the globe.
Contact us:
Consegic Business intelligence Pvt
Ltd.
Email: sales@consegicbusinessintelligence.com
Other Related Reports:
Chemotherapy Devices Market Share
Comments
Post a Comment